DRIO DRIO
Company Profile ↓Company Overview
DRIO (DRIO) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 24.2% CAGR over the past five years.
Trades at an undemanding P/E of 0.8.
Recent Developments
- Dec 2025 Revenue of $22.36M (-17.3% YoY); net profit $-41.71M.
- Trailing 12 Months Year-on-year growth — revenue -17.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 24.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 24.17% |
| 1 Year: | -17.31% |
Stock Price Performance
| 1 Year: | -30.36% |
| 6 Months: | -30.36% |
| 3 Months: | -4.13% |
| 1 Month: | +8.19% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)56.80 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 24.2% over 5 years.
CONS
- Trading 55.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 | 0 | 67.00K | 175.00K | 273.00K | 568.00K | 669.00K | 728.00K | 1.01M | 1.21M | 1.38M | 1.76M | 2.06M | 1.88M | 2.24M | 1.65M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | 0 | 0 | -421.00K | -605.00K | -585.00K | -230.00K | -235.00K | -131.00K | -102.00K | -157.00K | 76.00K | 106.00K | 360.00K | 276.00K | 552.00K | 522.00K | 468.00K | 558.00K | 326.00K | 873.00K | 779.00K | 636.00K | 549.00K | 1.08M | 1.51M | 826.00K | 3.98M | 1.14M | 1.80M | 3.17M | 2.07M | 610.00K | 2.43M | 2.76M | 3.88M | 3.88M | 2.96M | 3.02M | 3.20M |
| Operating Income | -3.08M | -3.60M | -3.24M | -2.67M | -3.60M | -2.51M | -1.78M | -1.51M | -2.55M | -1.92M | -2.62M | -2.72M | -4.21M | -4.12M | -2.98M | -2.92M | -5.79M | -4.05M | -5.36M | -5.36M | -2.80M | -10.11M | -4.12M | -6.60M | -14.33M | -18.00M | -22.50M | -15.87M | -17.36M | -14.57M | -12.41M | -14.02M | -15.55M | -17.86M | -16.19M | -12.03M | -9.41M | -9.20M | -9.48M | -7.31M |
| Net Income | -5.23M | -5.29M | -3.47M | -2.98M | -3.25M | -3.08M | -1.64M | -2.00M | -1.83M | -2.37M | -4.06M | -611.00K | -5.41M | -4.09M | -2.97M | -2.92M | -5.84M | -4.06M | -5.38M | -5.38M | -2.81M | -9.89M | -4.01M | -6.55M | -14.97M | -17.77M | -22.44M | -15.92M | -18.03M | -15.63M | -12.82M | -16.59M | -15.73M | -7.17M | -13.61M | -12.33M | -9.23M | -12.99M | -10.47M | -8.25M |
| Diluted EPS | -0.35 | -0.29 | -0.85 | -0.14 | -0.15 | -0.66 | - | -0.07 | -0.05 | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.68 | -0.71 | 0.92 | 0.99 | 1.18 | 0.74 | 0.74 | 0.64 | 0.45 | 0.58 | 0.49 | 0.20 | 0.08 | 4.91 | 2.87 | 0.18 | 2.96 | 1.25 |
| R&D Expense | 675.00K | 1.42M | 1.08M | 1.11M | 1.33M | 769.00K | 883.00K | 441.00K | 667.00K | 397.00K | 521.00K | 659.00K | 469.00K | 1.18M | 797.00K | 742.00K | 1.01M | 997.00K | 1.00M | 991.00K | 859.00K | 1.23M | 825.00K | 954.00K | 2.65M | 3.74M | 5.51M | 5.93M | 4.14M | 4.80M | 5.17M | 5.22M | 5.67M | 6.64M | 6.81M | 5.45M | 4.11M | 3.72M | 3.33M | 2.38M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | 0 | 51.00K | 823.00K | 2.80M | 5.17M | 7.39M | 7.56M | 7.58M | 20.51M | 27.66M | 20.35M | 27.04M | 22.36M |
| Gross Profit | - | 0 | -2.71M | -855.00K | -830.00K | 1.31M | 1.76M | 2.60M | 2.51M | 3.96M | 9.65M | 5.98M | 13.27M | 12.66M |
| Operating Income | -3.97M | -13.56M | -11.36M | -7.70M | -11.10M | -14.42M | -17.69M | -17.70M | -29.90M | -76.49M | -56.81M | -56.19M | -57.74M | -36.66M |
| Net Income | -5.69M | -13.93M | -12.88M | -7.14M | -10.89M | -15.74M | -17.80M | -17.74M | -29.45M | -76.76M | -62.19M | -59.43M | -42.75M | -41.71M |
| Diluted EPS | - | - | - | - | - | - | - | - | 4.01 | 4.07 | 2.54 | 1.93 | 12.27 | 10.12 |
| R&D Expense | 1.50M | 4.91M | 3.94M | 2.56M | 2.15M | 3.30M | 3.68M | 3.69M | 4.43M | 17.22M | 19.65M | 20.25M | 24.18M | 13.79M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Aug 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 2.32M | 4.12M | 3.08M | 5.08M | 3.87M | 6.96M | 14.09M | 24.57M | 35.41M | 100.77M | 119.19M | 96.39M | 118.88M | 110.08M |
| Total Equity | 0 | 193.14K | -1.07M | -86.00K | -5.29M | -1.58M | -6.54M | 3.94M | 8.93M | 18.89M | 28.15M | 85.55M | 80.00M | 58.14M | 72.02M | 67.92M |
| Cash & Equivalents | 0 | 908.76K | 1.23M | 2.26M | 1.45M | 2.67M | 1.09M | 3.72M | 11.00M | 20.39M | 28.59M | 35.81M | 49.36M | 36.80M | 27.76M | 21.80M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 0 | 18.11M | 24.59M | 23.47M | 30.75M |
| Current Liabilities | - | - | 566.75K | 1.51M | 1.62M | 1.69M | 2.92M | 3.02M | 5.16M | 5.22M | 7.03M | 14.38M | 19.35M | 12.49M | 16.64M | 9.32M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | -8.38M | -10.62M | -11.47M | -15.72M | -17.74M | -50.41M | -47.84M | -30.38M | -38.56M | -25.94M |
| Investing Cash Flow | - | - | - | - | -947.00K | -219.00K | -72.00K | -113.00K | -1.62M | -8.13M | -573.00K | -547.00K | -8.93M | -4.34M |
| Financing Cash Flow | - | - | - | - | 7.75M | 13.46M | 18.74M | 25.25M | 27.55M | 65.77M | 61.94M | 18.25M | 38.53M | 24.31M |
| Capital Expenditure | -534.63K | -1.40M | -563.00K | -110.00K | -808.00K | -195.00K | -71.00K | -98.00K | -118.00K | -261.00K | -442.00K | -584.00K | -138.00K | -142.00K |
| Free Cash Flow | - | - | - | - | -9.19M | -10.81M | -11.54M | -15.82M | -17.85M | -50.67M | -48.29M | -30.96M | -38.70M | -26.08M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | 134.00K | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | -5,317.6% | -103.9% | -29.6% | 25.4% | 23.9% | 34.4% | 33.2% | 19.3% | 34.9% | 29.4% | 49.1% | 56.6% |
| Operating Margin % | - | - | -22,270.6% | -935.4% | -396.0% | -278.9% | -239.2% | -234.2% | -394.7% | -372.9% | -205.4% | -276.1% | -213.6% | -163.9% |
| Net Margin % | - | - | -25,249.0% | -867.8% | -388.4% | -304.5% | -240.8% | -234.6% | -388.7% | -374.2% | -224.9% | -292.0% | -158.1% | -186.6% |
| ROE % | 531.5% | 16,198.8% | 243.2% | 452.0% | 166.4% | -399.5% | -199.5% | -93.9% | -104.6% | -89.7% | -77.7% | -102.2% | -59.4% | -61.4% |
| ROCE % | -227.3% | -519.6% | -775.3% | -227.3% | -1,172.2% | -365.8% | -198.2% | -91.5% | -105.4% | -88.5% | -56.9% | -67.0% | -56.5% | -36.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DRIO
Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience
DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced the launch of Dario's Integrated GLP-1 Program…
DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last?
DarioHealth (DRIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.…
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
DarioHealth Corp. (NASDAQ: DRIO) (the "Company," "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced that it has entered into securities purchase a…
Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced another Fortune 50 employer has selected Dario…
Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
DarioHealth Corp. (NASDAQ: DRIO) (the "Company," "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced the Company expects broader deployment of Dari…
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced a new agreement with a major health insurer with a stronghold in Arizona, entered into through its strategic chan…
DRIO — Frequently Asked Questions
What is the current share price of DRIO?
As of 2026-08-05 17:25 PDT, DRIO trades at $7.66 on NASDAQ/NYSE. Its 52-week range is $5.99 to $17.35.
What is the P/E ratio of DRIO?
DRIO trades at a trailing price-to-earnings (P/E) ratio of 0.76.
What is the return on equity (ROE) of DRIO?
DRIO has a return on equity (ROE) of -61.41%. Its return on capital employed (ROCE) is -36.38%.
Is DRIO a good stock to buy?
This page provides a data-driven analysis of DRIO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.